A Phase II Study of Tetrathiomolybdate in Patients With Breast Cancer at Moderate to High Risk of Recurrence
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Tetrathiomolybdate (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 11 Dec 2015 Planned End Date changed from 1 Jun 2014 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 11 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 07 Dec 2012 Planned End Date changed from 1 Dec 2010 to 1 Jun 2014 as reported by ClinicalTrials.gov.